AMANDA ALLEN: Open Payments
NPI 1689318578 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 6 companies in 2025. Trend: 2023 $169 · 2024 $24 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $49 |
| Dexcom, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| TOLMAR, INC. | 1 | $16 |
Products named: Ozempic, Dexcom G6 Transmitter, Auvelity, AUSTEDO XR, Wegovy, Veozah, JATENZO.
Industry payments across TX — which companies pay providers there.
